摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

malonic acid monophenethyl ester | 848598-50-5

中文名称
——
中文别名
——
英文名称
malonic acid monophenethyl ester
英文别名
3-Oxo-3-(2-phenylethoxy)propanoic acid
malonic acid monophenethyl ester化学式
CAS
848598-50-5
化学式
C11H12O4
mdl
——
分子量
208.214
InChiKey
XUWSQRZZDCBBRF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    376.3±25.0 °C(Predicted)
  • 密度:
    1.225±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    15
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    63.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis of trans-caffeate analogues and their bioactivities against HIV-1 integrase and cancer cell lines
    摘要:
    Forty caffeate analogues were synthesized via a convenient method starting from vanillin with moderate to good yields. The testing of biological activity of these compounds against HIV-1 integrase indicates that four compounds: bornyl caffeate, bornyl 2-nitrocaffeate, 5-nitrocaffeic acid and 5-nitrocaffeic acid phenethyl ester (5-nitroCAPE) possess a good HIV integrase inhibitory activity, IC50 19.9, 26.8, 25.0 and 13.5 mu M, respectively. Twelve caffeate analogues were tested by MTT assay on growth of human hepatocellular carcinoma BEL-7404, human breast MCF-7 adenocarcinoma, human lung A549 adenocarcinoma and human gastric cancer BCG823 cell lines, respectively. And the best result is IC50 5.5 mu M for CAPE against BEL-7404. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.10.046
  • 作为产物:
    描述:
    diphenethyl malonate氢氧化钾 作用下, 以 乙醇 为溶剂, 反应 1.0h, 以73.5%的产率得到malonic acid monophenethyl ester
    参考文献:
    名称:
    Xia, Chun-Nian; Hu, Wei-Xiao, Journal of Chemical Research, 2005, # 5, p. 332 - 334
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Method for producing organic compounds by substituting halogen atoms
    申请人:MITSUI CHEMICALS, INC.
    公开号:EP1486479A1
    公开(公告)日:2004-12-15
    The invention pertains to a method in which a halogen atom of an organic compound is replaced with a group derived from a nucleophilic agent, at high yield and high efficiency, by the following method which includes a step of reacting the nucleophilic agent with an organic material having a halogen atom bonded to a carbon atom having four σ bonds, more specifically: a method for producing an organic compound having Q, the method including a step of reacting a compound represented by general formula (2) with an organic starting material having at least one halogen atom bonded to a carbon atom having four σ bonds so as to replace the halogen atom in the organic starting material with Q:         MQa     (2) (wherein M represents an alkali metal atom, an alkali earth metal atom, or a rare earth metal atom; Q represents a moiety of an inorganic acid or an active hydrogen compound derived by eliminating a proton, wherein Q is a halogen atom different from the halogen atom in the organic starting material having the halogen atom bonded to the carbon atom having the four σ bonds; and a represents an integer of 1 to 3) in the presence of a compound represented by general formula (1) (wherein Z- represents an anion derived by eliminating a proton from an inorganic acid or an active hydrogen compound; R2 is the same or different; R2 each independently represent a C1-C10 hydrocarbon group or two R2 on the same nitrogen atom may be bonded with each other to form a ring with the nitrogen atom).
    这项发明涉及一种方法,其中有机化合物中的卤素原子被来自亲核试剂的基团取代,且产率高效率高,通过以下方法实现,包括以下步骤:将亲核试剂与具有与碳原子形成四个σ键的卤素原子相结合的有机材料反应的步骤,更具体地说:一种用于生产具有Q的有机化合物的方法,包括以下步骤:将由通式(2)表示的化合物与至少一个卤素原子与碳原子形成四个σ键的有机起始材料反应,以将有机起始材料中的卤素原子替换为Q:         MQa     (2) (其中M代表碱金属原子、碱土金属原子或稀土金属原子;Q代表由消除质子衍生的无机酸或活性氢化合物的基团,其中Q是不同于有机起始材料中卤素原子的卤素原子,该卤素原子与具有四个σ键的碳原子相结合;a表示1到3的整数),在通式(1)表示的化合物的存在下 (其中Z-代表由无机酸或活性氢化合物中消除质子衍生的阴离子;R2相同或不同;R2各自独立地表示C1-C10烃基,或者两个R2在同一氮原子上可能与彼此结合形成与氮原子的环)。
  • 咖啡酸苯乙酯的晶型II及其制备方法和用途
    申请人:北京欧德福瑞医药科技发展有限公司
    公开号:CN107337604A
    公开(公告)日:2017-11-10
    本发明提供咖啡酸苯乙酯的晶型II及其制备方法和用途,所述咖啡酸苯乙酯具有式I所示的结构,本发明的晶型II使用CuKα辐射的X‑射线粉末衍射图具有以下以2θ衍射角表示的衍射峰:6.199°、18.439°、22.560°、26.481°和30.721°。本发明的新晶型相对于其余形态稳定性好。本发明的新晶型的制备方法具有工艺简单、收率较高且稳定性好的特点。
  • Synthesis and characterization of CAPE derivatives as xanthine oxidase inhibitors with radical scavenging properties
    作者:Wonbeen Choi、Valente Villegas、Hannah Istre、Ben Heppler、Niki Gonzalez、Nicole Brusman、Lindsey Snider、Emily Hogle、Janelle Tucker、Alma Oñate、Sandra Oñate、Lili Ma、Stefan Paula
    DOI:10.1016/j.bioorg.2019.02.049
    日期:2019.5
    of the enzyme xanthine oxidase (XO) with radical scavenging properties hold promise as novel agents against reperfusion injuries after ischemic events. By suppressing the formation of damaging reactive oxygen species (ROS) by XO or scavenging ROS from other sources, these compounds may prevent a buildup of ROS in the aftermath of a heart attack or stroke. To combine these two properties in a single molecule
    具有自由基清除特性的黄嘌呤氧化酶(XO)酶抑制剂有望作为抵抗缺血事件后再灌注损伤的新型药物。通过抑制XO破坏性活性氧(ROS)的形成或从其他来源清除ROS,这些化合物可预防心脏病发作或中风后ROS的积聚。为了在单个分子中结合这两个特性,我们使用方便的微波辅助Knoevenagel缩合方案合成并表征了非嘌呤XO抑制剂咖啡酸苯乙酯(CAPE)和19种衍生物。系统地改变两个苯环上羟基的数量和位置,我们基于实验确定的XO抑制数据得出了结构活性关系。分子对接表明,关键的酶/抑制剂相互作用涉及酚类抑制剂环与Tyr914之间的π-π相互作用,抑制剂羟基与Glu802之间的氢键以及CAPE苯环与位于肽入口的非极性残基之间的疏水相互作用。结合位点。为了有效清除稳定的自由基DPPH,在苯环的1,2-或1,4-位需要两个羟基。在所有测试的化合物中,E-苯基3-(3,4-二羟基苯基)丙烯酸酯(一种不带乙基醚的CA
  • Intermediates for synthesis of vinblastine compound and method for synthesizing the intermediate
    申请人:——
    公开号:US20040034217A1
    公开(公告)日:2004-02-19
    Intermediates A, which are important in the whole synthesis of vindoline; and a method of synthesizing intermediates respectively represented by the general formulae B and C. By the method, the target intermediates are effectively synthesized with satisfactory reproducibility. This synthesis method is especially suitable for mass production. General formula A General formula B General formula C 1
    中间体A在维诺卡因的整个合成过程中非常重要;并且提供了分别用通式B和C表示的中间体的合成方法。通过这种方法,目标中间体可以有效地合成,并具有令人满意的可重复性。这种合成方法特别适合大规模生产。通式A、通式B和通式C1。
  • Mixed-blocked polyisocyanates and uses thereof
    申请人:——
    公开号:US20040067318A1
    公开(公告)日:2004-04-08
    Mixed and hybrid blocked polyisocyanates as cross linking agents in coating compositions, having at least one 1,3-dicarbonyl blocking group and at least one thermally active blocking group such that the molar ratio of 1,3-dicarbonyl blocking groups to thermally active blocking groups is in the range of from 4:1 to 1:9, offer improved intercoat adhesion when overcoated and good stability.
    混合和杂化阻化聚异氰酸酯作为涂料组分中的交联剂,具有至少一个1,3-二酮阻化基和至少一个热活性阻化基,使得1,3-二酮阻化基与热活性阻化基的摩尔比在4:1到1:9的范围内,提供了在涂覆上层涂料时改善的层间附着力和良好的稳定性。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐